The product is a highly efficient, inducible Cas9 D10A (Nickase)-Abca1 gene-editing based novel MMLV packaging system that can be used to mediate researches involving anti-HLA-B27 mab (S7N7NN2U) in Human B cell engineering.
| Clone | S7N7NN2U |
| Host | Human |
| Packaging Cell Line | GP-293 |
| Vector Promoter | CMV |
| Rep | Rep68 |
| Capsid | VP3 |
| Envelope | GP120 |
| Matrix | N-terminal |
| Size | ~30kb |
| Genome | dsDNA |
| Virus Type | MMLV |
| Cofactor Requirement | No ATP |
| Particles/mL | 6 × 10¹¹ |
| PFU/mL | 6.1 × 10¹¹ |
| TU/mL | 9.6 × 10¹¹ |
| Cas9 | Cas9 D10A (Nickase) |
| sgRNA | Abca1 |
| Engineered B Cell | Human B cells |
| Target | HLA-B27 |
| Alternative Names | HLA-B27; Human Leukocyte Antigen B27 |
| Format | Liquid |
| Shipping | The product is shipped by dry ice. |
| Storage | Upon receipt, store immediately at -80°C or lower for long-term storage. Avoid freeze/thaw cycles. |
Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.